Variant report

Variant	rs536607
Chromosome Location	chr6:13407088-13407089
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr6:13405977..13407729-chr6:13485216..13487161,3	MCF-7	breast:
2	chr6:13400278..13401808-chr6:13406310..13408265,2	MCF-7	breast:
3	chr6:13405420..13408218-chr6:13438666..13440547,2	K562	blood:
4	chr6:13406818..13408886-chr6:13483840..13488220,5	MCF-7	breast:
5	chr6:13406137..13408577-chr6:13573927..13576170,2	MCF-7	breast:
6	chr6:13406145..13408180-chr6:13453724..13455818,2	MCF-7	breast:
7	chr6:13395967..13397504-chr6:13405065..13407928,2	K562	blood:

Variant related genes	Relation type
ENSG00000187461	Chromatin interaction
ENSG00000237786	Chromatin interaction
ENSG00000124523	Chromatin interaction
ENSG00000145990	Chromatin interaction

Extended variants
information (count: 5 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:1)

rs_ID	r²[population]
rs541119	1.00[AMR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:4 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv532021	chr6:13232627-13805381	Active TSS Genic enhancers Strong transcription Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
2	nsv1028533	chr6:13239059-13484814	Enhancers Strong transcription Weak transcription ZNF genes & repeats Active TSS Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	23 gene(s)	inside rSNPs	diseases
3	nsv538136	chr6:13239059-13484814	Strong transcription Weak transcription Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Active TSS Genic enhancers ZNF genes & repeats Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	23 gene(s)	inside rSNPs	diseases
4	nsv1034016	chr6:13248122-13418225	Enhancers Flanking Active TSS Strong transcription Weak transcription Genic enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	22 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:70 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:13398400-13407400	Weak transcription	Placenta	Placenta
2	chr6:13401800-13419000	Weak transcription	Primary B cells from peripheral blood	blood
3	chr6:13403600-13409600	Enhancers	Primary monocytes fromperipheralblood	blood
4	chr6:13404000-13407400	Enhancers	Fetal Heart	heart
5	chr6:13404000-13408800	Enhancers	Brain Angular Gyrus	brain
6	chr6:13404000-13409000	Enhancers	Skeletal Muscle Male	skeletal muscle
7	chr6:13404200-13407200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
8	chr6:13404400-13407200	Enhancers	Brain Inferior Temporal Lobe	brain
9	chr6:13404400-13407400	Enhancers	A549	lung
10	chr6:13404400-13407800	Enhancers	NHLF	lung
11	chr6:13404400-13408200	Enhancers	Brain Cingulate Gyrus	brain
12	chr6:13404400-13408800	Enhancers	Adipose Nuclei	Adipose
13	chr6:13404400-13408800	Enhancers	Left Ventricle	heart
14	chr6:13404400-13408800	Enhancers	Psoas Muscle	Psoas
15	chr6:13404400-13408800	Enhancers	Right Atrium	heart
16	chr6:13404400-13409000	Enhancers	Skeletal Muscle Female	skeletal muscle
17	chr6:13404400-13411400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
18	chr6:13404800-13408600	Enhancers	Spleen	Spleen
19	chr6:13405000-13407200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
20	chr6:13405000-13407400	Enhancers	Hela-S3	cervix
21	chr6:13405000-13407600	Enhancers	Primary neutrophils fromperipheralblood	blood
22	chr6:13405000-13410200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
23	chr6:13405000-13418400	Weak transcription	Primary hematopoietic stem cells	blood
24	chr6:13405000-13421800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
25	chr6:13405200-13407600	Weak transcription	NHEK	skin
26	chr6:13405200-13408800	Enhancers	Brain Anterior Caudate	brain
27	chr6:13405400-13407200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
28	chr6:13405400-13407200	Weak transcription	Osteobl	bone
29	chr6:13405400-13407400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
30	chr6:13405400-13407400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
31	chr6:13405400-13407400	Weak transcription	HSMM	muscle
32	chr6:13405400-13407600	Weak transcription	Muscle Satellite Cultured Cells	--
33	chr6:13405400-13407600	Weak transcription	NH-A	brain
34	chr6:13405400-13407800	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
35	chr6:13405400-13409800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
36	chr6:13405400-13410400	Weak transcription	Aorta	Aorta
37	chr6:13405600-13407600	Enhancers	K562	blood
38	chr6:13405600-13408600	Enhancers	Fetal Muscle Leg	muscle
39	chr6:13405800-13407200	Enhancers	Stomach Mucosa	stomach
40	chr6:13406000-13408600	Enhancers	Duodenum Mucosa	Duodenum
41	chr6:13406000-13408800	Enhancers	Primary B cells from cord blood	blood
42	chr6:13406000-13408800	Enhancers	Lung	lung
43	chr6:13406000-13408800	Enhancers	Right Ventricle	heart
44	chr6:13406200-13407200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
45	chr6:13406200-13407200	Flanking Active TSS	Liver	Liver
46	chr6:13406200-13407200	Weak transcription	Rectal Smooth Muscle	rectum
47	chr6:13406200-13407800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
48	chr6:13406200-13409000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
49	chr6:13406400-13407400	Weak transcription	Sigmoid Colon	Sigmoid Colon
50	chr6:13406400-13408800	Flanking Active TSS	HepG2	liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links